{"title":"队列研究发现糖皮质激素会增加焦虑、抑郁的风险","authors":"","doi":"10.1002/pu.31359","DOIUrl":null,"url":null,"abstract":"<p>A population-based cohort study using both self-controlled and target trial emulation approaches has reported an association between use of oral glucocorticoids and increased risk of adverse psychiatric outcomes. Use of glucocorticoids was found to be associated with higher risk of depressive, bipolar, and anxiety disorders but did not increase risk of suicidality.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 10","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cohort study finds glucocorticoids increase risk of anxiety, depression\",\"authors\":\"\",\"doi\":\"10.1002/pu.31359\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A population-based cohort study using both self-controlled and target trial emulation approaches has reported an association between use of oral glucocorticoids and increased risk of adverse psychiatric outcomes. Use of glucocorticoids was found to be associated with higher risk of depressive, bipolar, and anxiety disorders but did not increase risk of suicidality.</p>\",\"PeriodicalId\":22275,\"journal\":{\"name\":\"The Brown University Psychopharmacology Update\",\"volume\":\"36 10\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Psychopharmacology Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pu.31359\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31359","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Cohort study finds glucocorticoids increase risk of anxiety, depression
A population-based cohort study using both self-controlled and target trial emulation approaches has reported an association between use of oral glucocorticoids and increased risk of adverse psychiatric outcomes. Use of glucocorticoids was found to be associated with higher risk of depressive, bipolar, and anxiety disorders but did not increase risk of suicidality.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
